| ★ | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | |
| 8 | Global Burden of Chronic Kidney Disease : Causes and Prevention in Young Adults | Medical Centric Podcast @medicalcentric | — | Portugal | 86 |
| 18 | Microalbuminuria : An Early Vascular Warning You Should Never Ignore | Medical Centric Podcast @medicalcentric | — | Portugal | 85 |
| 12 | How Chronic Kidney Disease Impacts Brain Function | Medical Centric Podcast @medicalcentric | 1.1K | Portugal | 85 |
| 7 | What to Know About eGFR-Based Decision-Making #kidneyfunction | | 693 | Estados Unidos | 86 |
| 14 | Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss | | 533 | Estados Unidos | 85 |
| 4 | SGLT2 EN ERC Beneficio en todos los estadios | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 383 | — | 87 |
| 16 | TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity | | 350 | Estados Unidos | 85 |
| 17 | Hemodiálisis incremental como forma de inicio del tratamiento sustitutivo renal | Fundación Renal Española @fundacionrenale | 275 | España | 85 |
| 10 | Beyond Bone Density: New Insights on Fracture Risk in Kidney Stone Patients | European Wellness @ewgroupofficial | 203 | Malasia | 86 |
| 9 | Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy | | 199 | Estados Unidos | 86 |
| 11 | Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA | | 179 | Estados Unidos | 86 |
| 20 | Rapid Evolution in GLP-1s and Therapeutics at ADA 2026 | | 171 | Estados Unidos | 85 |
| 2 | GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD | | 151 | Estados Unidos | 88 |
| 19 | AHA, ACC Release First-Ever Cardiovascular-Kidney-Metabolic Syndrome Guidelines | | 129 | Estados Unidos | 85 |
| 1 | FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD | | 123 | Estados Unidos | 94 |
| 5 | Overcoming Barriers to Diagnosis of CKD in Type 2 Diabetes | | 116 | Alemania | 87 |
| 15 | CALIBRATE: Encaleret Achieves Mineral Homeostasis in Patients With ADH1, With Rachel Gafni, MD | | 88 | Estados Unidos | 85 |
| 3 | GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy | | 80 | Estados Unidos | 88 |
| 13 | Diabetes Dialogue: The International Diabetes Federation and Care in India, With Amit Gupta, MBBS | | 79 | Estados Unidos | 85 |
| 6 | Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | 86 |